31 Mar 2020
Assets18.44
Total Income30.55
Profit After Tax0.06
NET Worth0.55
Reserves and Surplus0.51
At a glance
Updated 2026-09-18Dipna Pharmachem is a SME IPO with an issue size of ₹15.21 crore, proposed for listing on BSE SME. The offer opens on 25th Aug 2022 and closes on 30th Aug 2022. The issue structure includes a fresh issue of ₹14.43 crore.
Issue details
Listing atBSE SME
Issue typeFixed Price Issue
Issue size₹15.21 Cr
Fresh issue₹14.43 Cr
Face value₹10
Price band—–—
Listing8th Sep 2022
Grey market
GMP page ↗Latest GMP₹3.00
GMP / upper priceNO DATA
Est. listing₹41.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens25th Aug 2022
Closes30th Aug 2022
Listing8th Sep 2022
Subscription demand
Full bidding ↗Total2.77×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 3000 | — |
Company
Incorporated2011
Use of proceeds
| Object | Amount |
|---|---|
| Working capital requirement | ₹11.10 Cr |
| General Corporate Purpose | ₹3.65 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue72.77₹ Cr · +134.6% vs prior year
PAT1.17₹ Cr · +5,750.0% vs prior year
Assets36.23₹ Cr · +46.1% vs prior year
Net Worth1.74₹ Cr · +205.3% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2021
Assets24.79
Total Income31.02
Profit After Tax0.02
NET Worth0.57
Reserves and Surplus0.54
31 Mar 2022
Assets36.23
Total Income72.77
Profit After Tax1.17
NET Worth1.74
Reserves and Surplus1.70
KPIs
| KPI |
|---|
| RoNW |
Valuation & shareholding
Pre-IPO EPS333.40
Pre-IPO P/E39
Promoter holding pre100%
Promoter holding post66.57%
Market cap₹45.49 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Dipna Pharmachem IPO | — | 39.00 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Lead Manger Fees including Underwriting Commission | ₹0.18 Cr |
| Brokerage, selling commission and upload fees | ₹0.02 Cr |
| Registrar to the Issue | ₹0.01 Cr |
| Legal Advisors | ₹0.03 Cr |
| Advertising and marketing expenses | ₹0.05 Cr |
| Regulators including stock exchanges | ₹0.10 Cr |
| Printing and distribution of issue stationary | ₹0.01 Cr |
| Others (Market Making fees etc.) | ₹0.06 Cr |
Registrar & lead managers
Registrar
Bigshare Services Pvt.Ltd.Lead managers
- Interactive Financial Services Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-18.
IPO UPDATE ALERTS
Register for IPO Updates →Track Dipna Pharmachem without missing an update
Register for subscription, GMP, allotment and listing notifications.